Dysfunctional fat cells, lipotoxicity and type 2 diabetes

Positional cloning of the mouse obese gene and its human homologue

Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · see citing works

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518 · see citing works

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · see citing works

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915 · see citing works

Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity

Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856 · see citing works

The hormone resistin links obesity to diabetes

Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755 · see citing works

Weight-Reducing Effects of the Plasma Protein Encoded by the <i>obese</i> Gene

Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451 · see citing works

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543 · see citing works

Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia

Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541 · see citing works

Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor

Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,533 · see citing works

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238 · see citing works

Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients

Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · see citing works

Immunoassay of endogenous plasma insulin in man

Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041 · see citing works

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994

Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703 · see citing works

The mechanisms of action of PPARs

Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659 · see citing works

IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630 · see citing works

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526 · see citing works

The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM

DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · see citing works

Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome

Festa, A., D’Agostino, R., Howard, G., Mykkänen, L. M., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,363 · see citing works

A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction

Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346 · see citing works

Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes

Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321 · see citing works

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K. J., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,081 · see citing works

Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1

Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,012 · see citing works

Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency

Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998 · see citing works

Interleukin-6: an overview

Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890 · see citing works

The PPARs:  From Orphan Receptors to Drug Discovery

Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · see citing works

Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men

Chan, J. M., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1994) · Diabetes Care · doi:10.2337/diacare.17.9.961 · Cited by 1,808 · see citing works

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730 · see citing works

Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM

Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728 · see citing works

Banting Lecture 2001

McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435 · see citing works

Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α

Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390 · see citing works

Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women

Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339 · see citing works

Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity

Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · see citing works

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction

Boden, G., & Shulman, G. I. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.32.s3.3.x · Cited by 1,300 · see citing works

Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1 H NMR spectroscopy study

Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · see citing works

Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by¹³C Nuclear Magnetic Resonance Spectroscopy

Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248 · see citing works

Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action

Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179 · see citing works

Skeletal muscle triglyceride levels are inversely related to insulin action

Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179 · see citing works

Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · see citing works

Fatty acid-induced β cell apoptosis: A link between obesity and diabetes

Shimabukuro, M., Zhou, Y.-T., Levi, M., & Unger, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2498 · Cited by 1,142 · see citing works

"Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes.

Björntorp, P. A. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.4.493 · Cited by 1,115 · see citing works

Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications

Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100 · see citing works

Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss

Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096 · see citing works

Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus Monkeys

Hotta, K., Funahashi, T., Bodkin, N. L., Ortmeyer, H. K., Arita, Y., Hansen, B. C., & Matsuzawa, Y. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1126 · Cited by 1,072 · see citing works

Metabolic Implications of Body Fat Distribution

Björntorp, P. A. (1991) · Diabetes Care · doi:10.2337/diacare.14.12.1132 · Cited by 1,056 · see citing works

Diabetes trends in the U.S.: 1990-1998.

Mokdad, A. H., Ford, E. S., Bowman, B. A., Nelson, D. E., Engelgau, M. M., Vinicor, F., & Marks, J. S. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1278 · Cited by 1,042 · see citing works

Is Type II diabetes mellitus a disease of the innate immune system?

Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,040 · see citing works

Fuel selection in human skeletal muscle in insulin resistance: a reexamination.

Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017 · see citing works

Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

Saltiel, A. R., & Olefsky, J. M. (1996) · Diabetes · doi:10.2337/diab.45.12.1661 · Cited by 1,001 · see citing works

The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation

Frühbeck, G., Gómez‐Ambrosi, J., Muruzábal, F., & Burrell, M. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.6.e827 · Cited by 964 · see citing works

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

Combs, T. P., Berg, A. H., Obici, S., Scherer, P. E., & Rossetti, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14120 · Cited by 935 · see citing works

Insulin resistance and hypersecretion in obesity: European Group for the Study of Insulin Resistance (EGIR)

Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898 · see citing works

Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

Perseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877 · see citing works

Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ Health Study

Carey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willet, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009158 · Cited by 827 · see citing works

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.

Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · see citing works

Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus

Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794 · see citing works

Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM

Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I. (1988) · Diabetes · doi:10.2337/diab.37.8.1020 · Cited by 753 · see citing works

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

Kim, J. K., Fillmore, J. J., Chen, Y., Yu, C., Moore, I. K., Pypaert, M., Lutz, E. P., Kako, Y., Velez-Carrasco, W., Goldberg, I. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121164498 · Cited by 753 · see citing works

Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells

Gainsford, T., Willson, T. A., Metcalf, D., Handman, E., McFarlane, C., Ng, A. P., Nicola, N. A., Alexander, W. S., & Hilton, D. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14564 · Cited by 750 · see citing works

Resistin / Fizz3 Expression in Relation to Obesity and Peroxisome Proliferator–Activated Receptor-γ Action in Humans

Savage, D. B., Sewter, C. P., Klenk, E. S., Segal, D. G., Vidal‐Puig, A., Considine, R. V., & O’Rahilly, S. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2199 · Cited by 748 · see citing works

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

Miyazaki, Y., Mahankali, A., Matsuda, M., Mahankali, S., Hardies, J., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2002) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.87.6.8567 · Cited by 726 · see citing works

The Effect of Thiazolidinediones on Plasma Adiponectin Levels in Normal, Obese, and Type 2 Diabetic Subjects

Yu, J. G., Javorschi, S., Hevener, A. L., Kruszynska, Y. T., Norman, R. A., Sinha, M. K., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2968 · Cited by 724 · see citing works

A Lesson in Metabolic Regulation Inspired by the Glucokinase Glucose Sensor Paradigm

Matschinsky, F. (1996) · Diabetes · doi:10.2337/diab.45.2.223 · Cited by 721 · see citing works

Acute stimulation of glucose metabolism in mice by leptin treatment

Kamohara, S., Burcelin, R., Halaas, J. L., Friedman, J. M., & Charron, M. J. (1997) · Nature · doi:10.1038/38717 · Cited by 708 · see citing works

Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus

Goodpaster, B. H., Thaete, F. L., & Kelley, D. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.4.885 · Cited by 707 · see citing works

The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes

Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 694 · see citing works

Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo

Szczepaniak, L. S., Babcock, E. E., Schick, F., Dobbins, R. L., Garg, A., Burns, D. K., McGarry, J. D., & Stein, D. T. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.5.e977 · Cited by 688 · see citing works

Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling

Færgeman, N. J., & Knudsen, J. (1997) · Biochemical Journal · doi:10.1042/bj3230001 · Cited by 681 · see citing works

Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle.

Zhou, Y. P., & Grill, V. E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117042 · Cited by 677 · see citing works

Untitled work

(1997) · Diabetes reviews · Cited by 671 · see citing works

Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.

Kolterman, O. G., Insel, J., Saekow, M., & Olefsky, J. M. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109790 · Cited by 664 · see citing works

The Effects of Rosiglitazone on Insulin Sensitivity, Lipolysis, and Hepatic and Skeletal Muscle Triglyceride Content in Patients With Type 2 Diabetes

Mayerson, A. B., Hundal, R. S., Dufour, S., Lebon, V., Befroy, D., Cline, G. W., Enocksson, S., Inzucchi, S. E., Shulman, G. I., & Petersen, K. F. (2002) · Diabetes · doi:10.2337/diabetes.51.3.797 · Cited by 647 · see citing works

Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

Jacob, S., Machann, J., Rett, K., Brechtel, K., Volk, A., Renn, W., Maerker, E., Matthaei, S., Schick, F., Claussen, C. D., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1113 · Cited by 643 · see citing works

Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.

Aronoff, S., Rosenblatt, S., Braithwaite, S. S., Egan, J. W., Mathisen, A. L., & Schneider, R. (2000) · Diabetes Care · doi:10.2337/diacare.23.11.1605 · Cited by 626 · see citing works

A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids

Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617 · see citing works

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

Alessi, M., Peiretti, F., Morange, P., Henry, M., Nalbone, G., & Juhan-Vague, I. (1997) · Diabetes · doi:10.2337/diab.46.5.860 · Cited by 614 · see citing works

Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.

Goodpaster, B. H., Kelley, D. E., Wing, R. R., Meier, A., & Thaete, F. L. (1999) · Diabetes · doi:10.2337/diabetes.48.4.839 · Cited by 608 · see citing works

Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance

Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595 · see citing works

Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate

Schmitz-Peiffer, C., Craig, D. L., & Biden, T. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24202 · Cited by 592 · see citing works

Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets

Lupi, R., Dotta, F., Marselli, L., Guerra, S. D., Masini, M., Santangelo, C., Patanè, G., Boggi, U., Piro, S., Anello, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1437 · Cited by 590 · see citing works

Non-Insulin-Dependent Diabetes Mellitus — A Genetically Programmed Failure of the Beta Cell to Compensate for Insulin Resistance

Polonsky, K. S., Sturis, J., & Bell, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341207 · Cited by 590 · see citing works

Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes

Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566 · see citing works

DIABETES INCIDENCE IN PIMA INDIANS: CONTRIBUTIONS OF OBESITY AND PARENTAL DIABETES1

KNOWLER, W. C., PETTITT, D. J., SAVAGE, P. J., & BENNETT, P. H. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113079 · Cited by 561 · see citing works

Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B., & Karasik, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74276-8 · Cited by 550 · see citing works

Fatty acids, lipotoxicity and insulin secretion

McGarry, J., & Dobbins, R. L. (1999) · Diabetologia · doi:10.1007/s001250051130 · Cited by 548 · see citing works

Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists

Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10843 · Cited by 536 · see citing works

METABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION

Newgard, C. B., & McGarry, J. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · see citing works

Resistin and obesity-associated insulin resistance

Steppan, C. M., & Lazar, M. A. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00522-7 · Cited by 525 · see citing works

Adipose-derived resistin and gut-derived resistin-like molecule–β selectively impair insulin action on glucose production

Rajala, M. W., Obici, S., Scherer, P. E., & Rossetti, L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16521 · Cited by 525 · see citing works

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake

DeFronzo, R. A., Ferrannini, E., & Simonson, D. C. (1989) · Metabolism · doi:10.1016/0026-0495(89)90129-7 · Cited by 515 · see citing works

Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man

DeFronzo, R. A., Ferrannini, E., Hendler, R., Felig, P., & Wahren, J. (1983) · Diabetes · doi:10.2337/diab.32.1.35 · Cited by 509 · see citing works

Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo.

Cherrington, A. D. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1198 · Cited by 500 · see citing works

Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?

Prentki, M., & Corkey, B. E. (1996) · Diabetes · doi:10.2337/diab.45.3.273 · Cited by 478 · see citing works

Insulin Resistance in Morbid Obesity

Greco, A. V., Mingrone, G., Giancaterini, A., Manco, M., Morroni, M., Cinti, S., Granzotto, M., Vettor, R., Camastra, S., & Ferrannini, E. (2002) · Diabetes · doi:10.2337/diabetes.51.1.144 · Cited by 442 · see citing works

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.

Ryysy, L., Häkkinen, A. M., Goto, T., Vehkavaara, S., Westerbacka, J., Halavaara, J., & Yki-Järvinen, H. (2000) · Diabetes · doi:10.2337/diabetes.49.5.749 · Cited by 431 · see citing works

Differential Regulation of Adiponectin Secretion from Cultured Human Omental and Subcutaneous Adipocytes: Effects of Insulin and Rosiglitazone

Motoshima, H., Wu, X., Sinha, M. K., Hardy, V. E., Rosato, E. L., Barbot, D. J., Rosato, F. E., & Goldstein, B. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020635 · Cited by 425 · see citing works

Resistin, central obesity, and type 2 diabetes

McTernan, C. L., McTernan, P. G., Harte, A. L., Levick, P., Barnett, A. H., & Kumar, S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07281-1 · Cited by 421 · see citing works

Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone

Miyazaki, Y., Mahankali, A., Matsuda, M., Glass, L., Mahankali, S., Ferrannini, E., Cusi, K., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.710 · Cited by 407 · see citing works

Synthetic Peroxisome Proliferator-Activated Receptor-γ Agonist, Rosiglitazone, Increases Plasma Levels of Adiponectin in Type 2 Diabetic Patients

Yang, W., Jeng, C.-Y., Wu, T.-J., Tanaka, S., Funahashi, T., Matsuzawa, Y., Wang, J.-P., Chen, C., Tai, T., & Chuang, L. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.376 · Cited by 402 · see citing works

Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

Bogardus, C., Lillioja, S., Howard, B. V., Reaven, G. M., & Mott, D. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111533 · Cited by 397 · see citing works

Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver.

WILLIAMSON, J. R., Kreisberg, R. A., & Felts, P. W. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.56.1.247 · Cited by 390 · see citing works

Biology of regional body fat distribution: Relationship to non‐insulin‐dependent diabetes mellitus

Kissebah, A. H., & Peiris, A. N. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050202 · Cited by 384 · see citing works

PAI-1, Obesity, Insulin Resistance and Risk of Cardiovascular Events

Juhan-Vague, I., & Alessi, M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657607 · Cited by 381 · see citing works

β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats

Finegood, D. T., McArthur, M. D., Kojwang, D., Thomas, M. J., Topp, B. G., Leonard, T. B., & Buckingham, R. E. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1021 · Cited by 375 · see citing works

A 48-hour Lipid Infusion in the Rat Time-Dependently Inhibits Glucose-Induced Insulin Secretion and B Cell Oxidation Through a Process Likely Coupled to Fatty Acid Oxidation*

Sako, Y., & Grill, V. (1990) · Endocrinology · doi:10.1210/endo-127-4-1580 · Cited by 373 · see citing works

Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat.

Stein, D. T., Esser, V., Stevenson, B. E., Lane, K. E., Whiteside, J. H., Daniels, M. B., Chen, S., & McGarry, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118727 · Cited by 367 · see citing works

PPARγ knockdown by engineered transcription factors: exogenous PPARγ2 but not PPARγ1 reactivates adipogenesisPreprint

Ren, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P., & Camp, H. S. (2002) · Genes & Development · doi:10.1101/gad.953802 · Cited by 362 · see citing works

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.

Tripathy, D., Carlsson, M., Almgren, P., Isomaa, B., Taskinen, M., Tuomi, T., & Groop, L. (2000) · Diabetes · doi:10.2337/diabetes.49.6.975 · Cited by 361 · see citing works

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

Bajaj, M. S., Suraamornkul, S., Piper, P. K., Hardies, L. J., Glass, L. C., Cersósimo, E., Pratipanawatr, T., Miyazaki, Y., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031315 · Cited by 354 · see citing works

Increased Resistin Gene and Protein Expression in Human Abdominal Adipose Tissue

McTernan, P. G., McTernan, C. L., Chetty, R., Jenner, K., Fisher, F. M., Lauer, M. N., Crocker, J., Barnett, A. H., & Kumar, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8627 · Cited by 350 · see citing works

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

Alessi, M. C., Bastelica, D., Morange, P., Berthet, B., Leduc, I., Verdier, M., Geel, O., & Juhan-Vague, I. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1374 · Cited by 344 · see citing works

Inflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian

Krakoff, J. A., Funahashi, T., Stehouwer, C. D. A., Schalkwijk, C. G., Tanaka, S., Matsuzawa, Y., Kobes, S., Tataranni, P. A., Hanson, R. L., Knowler, W. C., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1745 · Cited by 334 · see citing works

Depot-related gene expression in human subcutaneous and omental adipocytes.

Montague, C. T., Prins, J. B., Sanders, L., Zhang, J., Sewter, C. P., Digby, J., Byrne, C. D., & O’Rahilly, S. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1384 · Cited by 331 · see citing works

Human Adipose Tissue Expresses Angiotensinogen and Enzymes Required for Its Conversion to Angiotensin II1

Karlsson, C., Lindell, K., Ottosson, M., Sjöström, L., Carlsson, B., & Carlsson, L. M. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5276 · Cited by 325 · see citing works

Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.

Gastaldelli, A., Baldi, S., Pettiti, M., Toschi, E., Camastra, S., Natali, A., Landau, B. R., & Ferrannini, E. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1367 · Cited by 320 · see citing works

Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.

Kelly, I. E., Han, T. S., Walsh, K., & Lean, M. E. J. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.288 · Cited by 314 · see citing works

β-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S.

Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312 · see citing works

Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics

Baron, A. D., Schaeffer, L., Shragg, P., & Kolterman, O. G. (1987) · Diabetes · doi:10.2337/diab.36.3.274 · Cited by 308 · see citing works

Pioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat

Haliakon, S., Doaré, L., Foufelle, F., Kergoat, M., Guerre-Millo, M., Berthault, M., Dugail, I., Morin, J., Auwerx, J. H., & Ferré, P. (1997) · Diabetes · doi:10.2337/diab.46.9.1393 · Cited by 306 · see citing works

The disposal of an oral glucose load in patients with non-insulin-dependent diabetes

Ferrannini, E., Simonson, D. C., Katz, L. D., Reichard, G., Bevilacqua, S., Barrett, E. J., Olsson, M., & DeFronzo, R. A. (1988) · Metabolism · doi:10.1016/0026-0495(88)90033-9 · Cited by 305 · see citing works

Adipsin and an endogenous pathway of complement from adipose cells.

Choy, L., Rosen, B. S., & Spiegelman, B. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42338-1 · Cited by 299 · see citing works

Effect of long chain triglyceride infusion on glucose metabolism in man

Thiébaud, D., DeFronzo, R. A., Jacot, E., Golay, A., Acheson, K. J., Maeder, E., Jéquier, E., & Felber, J. (1982) · Metabolism · doi:10.1016/0026-0495(82)90163-9 · Cited by 296 · see citing works

Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange

DeFronzo, R. A., Ferrannini, E., Hendler, R., Wahren, J., & Felig, P. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.5173 · Cited by 296 · see citing works

Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats.

Minokoshi, Y., Haque, M. S., & Shimazu, T. (1999) · Diabetes · doi:10.2337/diabetes.48.2.287 · Cited by 296 · see citing works

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

Weyer, C., Bogardus, C., & Pratley, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2197 · Cited by 292 · see citing works

Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes

Bajaj, M., Suraamornkul, S., Pratipanawatr, T., Hardies, L. J., Pratipanawatr, W., Glass, L. C., Cersósimo, E., Miyazaki, Y., & DeFronzo, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1364 · Cited by 291 · see citing works

Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus

Maggs, D. G., Buchanan, T. A., Burant, C., Cline, G. W., Gumbiner, B., Hsueh, W. A., Inzucchi, S., Kelley, D., Nolan, J., Olefsky, J. M., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00002 · Cited by 286 · see citing works

Mechanisms of the free fatty acid-induced increase in hepatic glucose production

Lam, T. K. T., Carpentier, A. C., Lewis, G. F., van de Werve, G., Fantus, I. G., & Giacca, A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00033.2003 · Cited by 283 · see citing works

The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents

Gulli, G., Ferrannini, E., Stern, M., Haffner, S., & DeFronzo, R. A. (1992) · Diabetes · doi:10.2337/diab.41.12.1575 · Cited by 283 · see citing works

Effect of troglitazone on body fat distribution in type 2 diabetic patients.

Mori, Y., Murakawa, Y., Okada, K., Horikoshi, H., Yokoyama, J., Tajima, N., & Ikeda, Y. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.908 · Cited by 281 · see citing works

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

Miyazaki, Y., Glass, L. C., Triplitt, C. L., Matsuda, M., Cusi, K. J., Mahankali, A., Mahankali, S., Mandarino, L. J., & DeFronzo, R. A. (2001) · Diabetologia · doi:10.1007/s001250100031 · Cited by 274 · see citing works

Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle

Ellis, B. A., Poynten, A., Lowy, A. J., Furler, S. M., Chisholm, D. J., Kraegen, E. W., & Cooney, G. J. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e554 · Cited by 273 · see citing works

SEQUENTIAL CHANGES IN SERUM INSULIN CONCENTRATION DURING DEVELOPMENT OF NON-INSULIN-DEPENDENT DIABETES

Saad, M., Pettitt, D., Mott, D., Knowler, W., Nelson, R., & Bennett, P. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92804-3 · Cited by 265 · see citing works

Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors.

Clausen, J. O., Borch-Johnsen, K., Ibsen, H., Bergman, R. N., Hougaard, P., Winther, K., & Pedersen, O. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118903 · Cited by 259 · see citing works

Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation

Carpentier, A. C., Mittelman, S. D., Lamarche, B., Bergman, R. N., Giacca, A., & Lewis, G. F. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.6.e1055 · Cited by 252 · see citing works

Mapping of Early Signaling Events in Tumor Necrosis Factor-α-mediated Lipolysis in Human Fat Cells

Rydén, M., Dicker, A., van Harmelen, V., Hauner, H., Brunnberg, M., Perbeck, L. G., Lönnqvist, F., & Arner, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109498200 · Cited by 249 · see citing works

New Oral Therapies for Type 2 Diabetes Mellitus: The Glitazones or Insulin Sensitizers

Mudaliar, S. R. D., & Henry, R. R. (2001) · Annual Review of Medicine · doi:10.1146/annurev.med.52.1.239 · Cited by 247 · see citing works

Protein Kinase C Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation Requires Serine 612

Fea, K. D., & Roth, R. A. (1997) · Biochemistry · doi:10.1021/bi971157f · Cited by 246 · see citing works

Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat

Hallakou, S., Doaré, L., Foufelle, F., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.9.1393 · Cited by 243 · see citing works

Long term exposure to fatty acids and ketones inhibits B-cell functions in human pancreatic islets of Langerhans

Zhou, Y. P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.5.1584 · Cited by 243 · see citing works

Circulating Tumor Necrosis Factor-α Concentrations in a Native Canadian Population with High Rates of Type 2 Diabetes Mellitus1

Zinman, B., Hanley, A. J., Harris, S. B., Kwan, J., & Fantus, I. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5405 · Cited by 239 · see citing works

Dose-Response Effect of Pioglitazone on Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes

Miyazaki, Y., Matsuda, M., & DeFronzo, R. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.517 · Cited by 236 · see citing works

Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats

Higa, M., Zhou, Y.-T., Ravazzola, M., Baetens, D., Orci, L., & Unger, R. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11513 · Cited by 235 · see citing works

Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects

Bevilacqua, S., Bonadonna, R. C., Buzzigoli, G., Boni, C. D., Ciociaro, D., Maccari, F., Giorico, M. A., & Ferrannini, E. (1987) · Metabolism · doi:10.1016/0026-0495(87)90051-5 · Cited by 233 · see citing works

Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.

Carpentier, A. C., Mittelman, S. D., Bergman, R. N., Giacca, A., & Lewis, G. F. (2000) · Diabetes · doi:10.2337/diabetes.49.3.399 · Cited by 222 · see citing works

The fourth Musketeer ? from Alexandre Dumas to Claude Bernard

Reaven, G. M. (1995) · Diabetologia · doi:10.1007/s001250050247 · Cited by 221 · see citing works

Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway

Zierath, J. R., Livingston, J. N., Thörne, A., Bolinder, J., Reynisdottir, S., Lönnqvist, F., & Arner, P. (1998) · Diabetologia · doi:10.1007/s001250051075 · Cited by 218 · see citing works

Control of Gluconeogenesis in Liver

Exton, J. H., Corbin, J. G., & Park, C. R. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36389-5 · Cited by 217 · see citing works

Protein Kinase C-ζ Phosphorylates Insulin Receptor Substrate-1 and Impairs Its Ability to Activate Phosphatidylinositol 3-Kinase in Response to Insulin

Ravichandran, L. V., Esposito, D. L., Chen, J. Y. ‐., & Quon, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007231200 · Cited by 217 · see citing works

Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects

Paolisso, G., Gambardella, A., Amato, L., Tortoriello, R., D'Amore, A., Varricchio, M., & D'Onofrio, F. (1995) · Diabetologia · doi:10.1007/bf00401761 · Cited by 217 · see citing works

Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance.

Cavaghan, M. K., Ehrmann, D. A., Byrne, M. M., & Polonsky, K. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119562 · Cited by 216 · see citing works

Humoral Regulation of Resistin Expression in 3T3-L1 and Mouse Adipose Cells

Shojima, N., Sakoda, H., Ogihara, T., Fujishiro, M., Katagiri, H., Anai, M., Onishi, Y., Ono, H., Inukai, K., Abe, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1737 · Cited by 207 · see citing works

Mechanisms of the Stimulation of Insulin Release by Saturated Fatty Acids: A Study of Palmitate Effects in Mouse β-cells

Warnotte, C., Gilon, P., Nenquin, M., & Henquin, J. (1994) · Diabetes · doi:10.2337/diab.43.5.703 · Cited by 206 · see citing works

Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system

Hunter, S. J., & Garvey, W. T. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00300-3 · Cited by 200 · see citing works

Relation Between Plasma Tumor Necrosis Factor-α and Insulin Sensitivity in Elderly Men With Non–Insulin-Dependent Diabetes Mellitus

Nilsson, J. Å., Jovinge, S. V., Niemann, A., Reneland, R., & Lithell, H. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.8.1199 · Cited by 200 · see citing works

Insulin signaling in the arterial wall

Hsueh, W. A., & Law, R. E. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00353-7 · Cited by 200 · see citing works

Thiazolidinediones and insulin resistance: Peroxisome proliferatoractivated receptor γ activation stimulates expression of the CAP gene

Ribon, V., Johnson, J. H., Camp, H. S., & Saltiel, A. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14751 · Cited by 196 · see citing works

Human Resistin Gene: Molecular Scanning and Evaluation of Association with Insulin Sensitivity and Type 2 Diabetes in Caucasians

Wang, H., Chu, W. S., Hemphill, C., & Elbein, S. C. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8528 · Cited by 193 · see citing works

Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans.

Roden, M., Krššák, M., Stingl, H., Gruber, S., Hofer, A., Fürnsinn, C., Moser, E., & Waldhäusl, W. K. (1999) · Diabetes · doi:10.2337/diabetes.48.2.358 · Cited by 189 · see citing works

Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance

Reaven, G. M., Hollenbeck, C. B., & Chen, Y. D. I. (1989) · Diabetologia · doi:10.1007/bf00265404 · Cited by 186 · see citing works

Peripheral metabolic actions of leptin

Muoio, D. M., & Lynis Dohm, G. (2002) · Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism · doi:10.1053/beem.2002.0223 · Cited by 183 · see citing works

Cell-mediated immunity in genetically obese (C57BL/6J ob/ob) mice

Chandra, R. K. (1980) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.1.13 · Cited by 179 · see citing works

The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.

Després, J., Lemieux, S., Lamarche, B., homme, D. P., Moorjani, S., Brun, L., Gagné, C., & Lupien, P. J. (1995) · PubMed · Cited by 178 · see citing works

Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.

Mason, T. M., Goh, T., Tchipashvili, V, Sandhu, H., Gupta, N., Lewis, G. F., & Giacca, A. (1999) · Diabetes · doi:10.2337/diabetes.48.3.524 · Cited by 177 · see citing works

Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men

Seppala-Lindroos, A. (2002) · Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.87.7.3023 · Cited by 168 · see citing works

Fatty Acid-Induced Insulin Resistance: Decreased Muscle PI3K Activation But Unchanged Akt Phosphorylation

Kruszynska, Y. T., Worrall, D. S., Ofrecio, J. M., Frías, J. P., Macaraeg, G. B., & Olefsky, J. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8187 · Cited by 167 · see citing works

An adipocentric view of signaling and intracellular trafficking

Mora, S., & Pessin, J. E. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.321 · Cited by 167 · see citing works

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients

Bajaj, M., Suraamornkul, S., Hardies, L. J., Pratipanawatr, T., & DeFronzo, R. A. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802625 · Cited by 159 · see citing works

Inhibition by insulin of resistin gene expression in 3T3‐L1 adipocytes

Haugen, F., Jørgensen, A., Drevon, C. A., & Trayhurn, P. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02968-4 · Cited by 158 · see citing works

Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.

Vauhkonen, I., NISKANEN, L. K., Vanninen, E. J., Kainulainen, S., Uusitupa, M. I. J., & Laakso, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci716 · Cited by 154 · see citing works

Regional differences in protein production by human adipose tissue

Arner, P. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290072 · Cited by 151 · see citing works

Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients

Miyazaki, Y., Pipek, R., Mandarino, L. J., & DeFronzo, R. A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802187 · Cited by 148 · see citing works

Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals

Golay, A., Swislocki, A., Chen, Y. I., & Reaven, G. M. (1987) · Metabolism · doi:10.1016/0026-0495(87)90156-9 · Cited by 147 · see citing works

Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women.

Bonora, E., Prato, S. D., Bonadonna, R. C., Gulli, G., Solini, A., shank, M. L., Ghiatas, A. A., Lancaster, J. L., Kilcoyne, R. F., & Alyassin, A. M. (1992) · PubMed · Cited by 145 · see citing works

Mechanisms Regulating Adipocyte Expression of Resistin

Hartman, H. B., Hu, X., Tyler, K. X., Dalal, C. K., & Lazar, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201451200 · Cited by 145 · see citing works

Plasma acylation stimulating protein, adipsin and lipids in non‐obese and obese populations

Maslowska, Vu, Phelis, Sniderman, Rhode, Blank, & Cianflone (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00514.x · Cited by 144 · see citing works

Regional adipocity in man

Arner, P. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1550191 · Cited by 140 · see citing works

Does Intra-Abdominal Adipose Tissue in Black Men Determine Whether NIDDM Is Insulin-Resistant or Insulin-Sensitive?

Banerji, M. A., Chaiken, R. L., Gordon, D., Kral, J. G., & Lebovitz, H. E. (1995) · Diabetes · doi:10.2337/diab.44.2.141 · Cited by 138 · see citing works

Comparing effects of leptin and insulin on glucose metabolism in skeletal muscle: evidence for an effect of leptin on glucose uptake and decarboxylation

Ceddia, R. B., William, W., & Curi, R. A. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800762 · Cited by 132 · see citing works

Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance.

Thompson, A. L., & Cooney, G. J. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1761 · Cited by 132 · see citing works

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions

Cianflone, K., Maslowska, M., & Sniderman, A. D. (1999) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1998.0272 · Cited by 131 · see citing works

Metabolic basis of obesity and noninsulin‐dependent diabetes mellitus

Golay, A., Jp, F., Jéquier, E., DeFronzo, R. A., & Ferrannini, E. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040803 · Cited by 131 · see citing works

Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?

Js, Y. (1999) · PubMed · Cited by 131 · see citing works

Acute and Chronic Responses of Skeletal Muscle to Endurance and Sprint Exercise

Abernethy, P. J., Thayer, R., & Taylor, A. W. (1990) · Sports Medicine · doi:10.2165/00007256-199010060-00004 · Cited by 129 · see citing works

Interleukin-6 Affects Insulin Secretion and Glucose Metabolism of Rat Pancreatic Isletsin Vitro*

Sandler, S., Bendtzen, K., Eizirik, D. L., & Welsh, M. (1990) · Endocrinology · doi:10.1210/endo-126-2-1288 · Cited by 129 · see citing works

Troglitazone but not Metformin Restores Insulin-Stimulated Phosphoinositide 3-Kinase Activity and Increases p110β Protein Levels in Skeletal Muscle of Type 2 Diabetic Subjects

Kim, Y., Ciaraldi, T. P., Kong, A. P. S., Kim, D. S., Chu, N. V., Mohideen, P., Mudaliar, S. R. D., Henry, R. R., & Kahn, B. B. (2002) · Diabetes · doi:10.2337/diabetes.51.2.443 · Cited by 127 · see citing works

Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone

Sreenan, S., Sturis, J., Pugh, W., Burant, C., & Polonsky, K. S. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.4.e742 · Cited by 125 · see citing works

Induction of Hepatic Glucose-6-Phosphatase Gene Expression by Lipid Infusion

Massillon, D., Barzilai, N., Hawkins, M. A., Prus-Wertheimer, D., & Rossetti, L. (1997) · Diabetes · doi:10.2337/diab.46.1.153 · Cited by 125 · see citing works

Effect of Troglitazone on Fibrinolysis and Activated Coagulation in Patients With Non–Insulin-Dependent Diabetes Mellitus

Fonseca, V. A., Reynolds, T., Hemphill, D., Randolph, C., Wall, J., Valiquett, T. R., Graveline, J. F., & Fink, L. M. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00109-8 · Cited by 123 · see citing works

How obesity causes diabetes in Zucker diabetic fatty rats

Unger, R. E. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00094-5 · Cited by 119 · see citing works

Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation

Pratipanawatr, W., Pratipanawatr, T., Cusi, K., Berria, R., Adams, J. M., Jenkinson, C. P., Maezono, K., DeFronzo, R. A., & Mandarino, L. J. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2572 · Cited by 118 · see citing works

Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase.

Wititsuwannakul, D., & Kim, K. H. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41039-8 · Cited by 116 · see citing works

Leptin as a Therapeutic Agent--Trials and Tribulations

Mantzoros, C. S., & Flier, J. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.7062 · Cited by 115 · see citing works

High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease.

Yudkin, J. S., Yajnik, C. S., Mohamed‐Ali, V., & Bulmer, K. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.363 · Cited by 113 · see citing works

Troglitazone Monotherapy Improves Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled Study1

Fonseca, V. A., Valiquett, T. R., Huang, S. M., Ghazzi, M. N., & Whitcomb, R. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5123 · Cited by 110 · see citing works

Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays.

Fernandes, G., Handwerger, B. S., Yunis, E. J., & Brown, D. M. (1978) · Journal of Clinical Investigation · doi:10.1172/jci108933 · Cited by 106 · see citing works

Effects of Acute and Chronic Exercise on Fat Metabolism

MARTIN, W. H. (1996) · Exercise and Sport Sciences Reviews · doi:10.1249/00003677-199600240-00009 · Cited by 105 · see citing works

Role of Cytokines in the Regulation of Plasminogen Activator Inhibitor-1 Expression and Secretion in Newly Differentiated Subcutaneous Human Adipocytes

Birgel, M., Gottschling-Zeller, H., Röhrig, K., & Hauner, H. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1682 · Cited by 103 · see citing works

From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus.

DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016 · see citing works

Pathogenesis of type 2 diabetes mellitus

DeFronzo, R. A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.013 · Cited by 1,342 · see citing works

Fat tissue, aging, and cellular senescence

Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094 · see citing works

Autophagy Is Important in Islet Homeostasis and Compensatory Increase of Beta Cell Mass in Response to High-Fat Diet

Ebato, C., Uchida, T., Arakawa, M., Komatsu, M., Ueno, T., Komiya, K., Azuma, K., Hirose, T., Tanaka, K., Kominami, E., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.009 · Cited by 774 · see citing works

Aging in adipocytes: Potential impact of inherent, depot-specific mechanisms

CARTWRIGHT, M., TCHKONIA, T., & KIRKLAND, J. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.03.003 · Cited by 318 · see citing works

What is lipotoxicity?

Engin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260 · see citing works

Diabetes and beta cell function: from mechanisms to evaluation and clinical implications

Cernea, S., & Dobreanu, M. (2013) · Biochemia Medica · doi:10.11613/bm.2013.033 · Cited by 203 · see citing works

Sleep restriction increases free fatty acids in healthy men

Broussard, J. L., Chapotot, F., Abraham, V., Day, A., Delebecque, F., Whitmore, H. R., & Tasali, E. (2015) · Diabetologia · doi:10.1007/s00125-015-3500-4 · Cited by 156 · see citing works

Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals

Garito, T., Roubenoff, R., Hompesch, M., Morrow, L., Gomez, K., Rooks, D., Meyers, C., Buchsbaum, M. S., Neelakantham, S., Swan, T., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13042 · Cited by 88 · see citing works

Relationships between Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes Mellitus

van de Weijer, T., Sparks, L. M., Phielix, E., Meex, R. C., van Herpen, N. A., Hesselink, M. K. C., Schrauwen, P., & Schrauwen-Hinderling, V. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0051648 · Cited by 87 · see citing works

Exercise training improves adipose tissue metabolism and vasculature regardless of baseline glucose tolerance and sex.

Honkala, S. M., Motiani, P., Kivelä, R., Hemanthakumar, K. A., Tolvanen, E., Motiani, K. K., Eskelinen, J.-J., Virtanen, K. A., Kemppainen, J., Heiskanen, M. A., et al. (2020) · BMJ Open Diabetes Research &amp; Care · doi:10.1136/bmjdrc-2019-000830 · Cited by 37 · see citing works

The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans

Palavicini, J. P., Chavez-Velazquez, A., Fourcaudot, M., Tripathy, D., Pan, M., Norton, L., DeFronzo, R. A., & Shannon, C. E. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.784391 · Cited by 36 · see citing works

Effects of immobilization and aerobic training on proteins related to intramuscular substrate storage and metabolism in young and older men

Vigelsø, A., Gram, M., Wiuff, C., Hansen, C. N., Prats, C., Dela, F., & Helge, J. W. (2016) · European Journal of Applied Physiology · doi:10.1007/s00421-015-3302-x · Cited by 13 · see citing works

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ

Атабекова, Б. Б. (2024) · Habaršy. Pedagogika ġylymdary seriâsy · doi:10.51889/2959-5762.2023.80.4.019

Obesity and Diabetes: Lipotoxicity

Lelliott, C. J., Orešič, M., & Vidal‐Puig, A. (2010) · Wiley eBooks · doi:10.1002/9783527629527.ch18

Advances of Research on Lipotoxicity and Nonalcoholic Fatty Liver Disease

Zhang, L. (2008) · Huaxi yixue

Lipotoxicity and immunometabolism in ischemic acute kidney injury: current perspectives and future directions

Otunla, A. A., Shanmugarajah, K., Davies, A. H., & Shalhoub, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1355674 · Cited by 13 · see citing works